Intelligent Bio Solutions Inc. (INBS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $5.84M
Last updated: Nov 17, 2026 at 11:03 AM ET
Intelligent Bio Solutions Inc. (INBS) Stock Forecast
Analysts expect Intelligent Bio Solutions (INBS) to earn -$5.18 per share in the fiscal year ending Jun 30, 2027, on revenue of $6.10M. For the fiscal year ending Jun 30, 2028, the EPS consensus is -$4.06.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 44.3%.
- Fiscal year ending Jun 30, 2027
- -$5.18
- EPS consensus, revenue $6.10M
- Fiscal year ending Jun 30, 2028
- -$4.06
- EPS consensus, revenue $8.80M
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Jun 30, 2027 | -$5.18 | -$5.18 to -$5.18 | 1 | $6.10M | $6.10M to $6.10M | 1 |
| Jun 30, 2028 | -$4.06 | -$4.06 to -$4.06 | 1 | $8.80M | $8.80M to $8.80M | 1 |
Quarterly Estimates
Across the 3 quarters below, the EPS consensus is lowest for the quarter ending Dec 31, 2026, at -$1.36, and highest for the quarter ending Jun 30, 2027, at -$1.20.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$1.36 | -$1.36 to -$1.36 | 1 | $1.40M | $1.40M to $1.40M | 1 |
| Mar 31, 2027 | -$1.33 | -$1.33 to -$1.33 | 1 | $1.50M | $1.50M to $1.50M | 1 |
| Jun 30, 2027 | -$1.20 | N/A | 3 | $1.84M | $1.76M to $1.89M | 3 |
Estimate Revisions
No EPS estimate for the 4 periods below was revised in the last 30 days.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Jun 30, 2027 | 0 | 0 |
| Fiscal year ending Jun 30, 2028 | 0 | 0 |
| Quarter ending Dec 31, 2026 | 0 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
The EPS consensus for the fiscal year ending Jun 30, 2027 has held over the last 60 days.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Jun 30, 2027 | -$5.18 | -$5.18 | -$5.18 | -$5.18 | N/A | N/A |
| Fiscal year ending Jun 30, 2028 | -$4.06 | -$4.06 | -$4.06 | -$4.06 | N/A | N/A |
| Quarter ending Dec 31, 2026 | -$1.36 | -$1.36 | -$1.36 | -$1.36 | N/A | N/A |
| Quarter ending Mar 31, 2027 | -$1.33 | -$1.33 | -$1.33 | -$1.33 | N/A | N/A |
Frequently Asked Questions About INBS
What is the INBS stock forecast?
Consensus analyst estimates put Intelligent Bio Solutions's EPS at -$5.18 for the fiscal year ending Jun 30, 2027, on revenue of $6.10M.
What EPS do analysts expect from INBS next year?
For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is -$5.18, with estimates from -$5.18 to -$5.18 from 1 analyst. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is -$4.06, with estimates from -$4.06 to -$4.06 from 1 analyst.
What revenue do analysts expect from Intelligent Bio Solutions next year?
For the fiscal year ending Jun 30, 2027, the consensus revenue estimate is $6.10M, with estimates from $6.10M to $6.10M. For the fiscal year ending Jun 30, 2028, the consensus revenue estimate is $8.80M, with estimates from $8.80M to $8.80M.
How many analysts cover INBS?
1 analyst estimates EPS for Intelligent Bio Solutions for the fiscal year ending Jun 30, 2027.
INBS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors